Stoxx Europe 50
4.440,12
PKT
+1,78
PKT
+0,04
%
Werbung
Analysen zu Stoxx Europe 50-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 06.02.25 | Novo Nordisk Buy | UBS AG | |
| 06.02.25 | Nestlé Neutral | UBS AG | |
| 06.02.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 06.02.25 | Rio Tinto Neutral | UBS AG | |
| 06.02.25 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 06.02.25 | Roche Sell | Goldman Sachs Group Inc. | |
| 06.02.25 | Santander Buy | UBS AG | |
| 06.02.25 | GSK Neutral | UBS AG | |
| 06.02.25 | TotalEnergies Neutral | Goldman Sachs Group Inc. | |
| 06.02.25 | UBS Buy | Goldman Sachs Group Inc. | |
| 06.02.25 | Deutsche Telekom Overweight | JP Morgan Chase & Co. | |
| 06.02.25 | TotalEnergies Overweight | JP Morgan Chase & Co. | |
| 05.02.25 | BNP Paribas Halten | DZ BANK | |
| 05.02.25 | Airbus Kaufen | DZ BANK | |
| 05.02.25 | GSK Neutral | Goldman Sachs Group Inc. | |
| 05.02.25 | Diageo Outperform | Bernstein Research | |
| 05.02.25 | Diageo Sell | Deutsche Bank AG | |
| 05.02.25 | BNP Paribas Buy | Deutsche Bank AG | |
| 05.02.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 05.02.25 | GSK Outperform | Bernstein Research | |
| 05.02.25 | GSK Neutral | UBS AG | |
| 05.02.25 | TotalEnergies Outperform | RBC Capital Markets | |
| 05.02.25 | BAT Neutral | Goldman Sachs Group Inc. | |
| 05.02.25 | Intesa Sanpaolo Buy | Goldman Sachs Group Inc. | |
| 05.02.25 | Santander Buy | Goldman Sachs Group Inc. | |
| 05.02.25 | EssilorLuxottica Buy | Goldman Sachs Group Inc. | |
| 05.02.25 | Diageo Sell | Goldman Sachs Group Inc. | |
| 05.02.25 | Zurich Insurance Hold | Deutsche Bank AG | |
| 05.02.25 | AXA Buy | Deutsche Bank AG | |
| 05.02.25 | Allianz Buy | Deutsche Bank AG | |
| 05.02.25 | Diageo Buy | UBS AG | |
| 05.02.25 | TotalEnergies Buy | UBS AG | |
| 05.02.25 | LOréal Underweight | JP Morgan Chase & Co. | |
| 05.02.25 | BASF Neutral | JP Morgan Chase & Co. | |
| 05.02.25 | TotalEnergies Neutral | Goldman Sachs Group Inc. | |
| 05.02.25 | GSK Underweight | JP Morgan Chase & Co. | |
| 05.02.25 | Novo Nordisk Buy | UBS AG | |
| 05.02.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 05.02.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 05.02.25 | Santander Buy | UBS AG |